This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Embryonic kidney cell (HEK293T)
Liver cancer cells (HepG2)
Liver cancer cells (MHCC-97L)
Plasma
By sample status
Multiple myeloma patients
Normal
Sample A_Biooscientific
Sample B_Biooscientific
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-505-3p
MIMAT0002876
7.7e-9
4.8e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
2.8e-6
4.9e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
2.2e-8
4.7e-1
Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types.
BMC Genomics. 2012 Aug 1;13:357. doi: 10.1186/1471-2164-13-357.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
0.0e+0
4.5e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
0.0e+0
4.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
0.0e+0
4.6e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000217_2
7
/
0
/
7
hsa-miR-505-3p
MIMAT0002876
3.3e-2
3.3e-2
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000217_2
7
/
0
/
7
[1]